USA flag logo/image

An Official Website of the United States Government

Spectroscopic optical cohernece tomography for intravascular imaging

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
89320
Program Year/Program:
2008 / SBIR
Agency Tracking Number:
HL092690
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
Southwest Sciences, Inc.
1570 Pacheco St. Suite E-11 Santa Fe, NM 87505-3993
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: Yes
 
Phase 1
Fiscal Year: 2008
Title: Spectroscopic optical cohernece tomography for intravascular imaging
Agency: HHS
Contract: 1R43HL092690-01
Award Amount: $112,931.00
 

Abstract:

DESCRIPTION (provided by applicant): The overall objective of this SBIR project is the development of a rapid, high resolution optical method for in vivo imaging with a specific emphasis on intravascular imaging and the identification of vulnerable plaque. The approach uses a novel harmonic detection method for optical coherence tomography (OCT) that will allow depth resolved near infrared spectroscopy in conjunction with structural imaging. Since different structures in atherosclerotic plaques, such as the fibrotic caps, lipid pools and calcifications have different near infrared spectroscopic features, spectroscopic OCT is a promising approach to enhancing contrast in optical coherence tomography. Southwest Sciences recently developed a harmonic detect ion method for optical coherence tomography for the removal of artifacts inherent to Fourier domain OCT, but the method can also be used to provide the phase information necessary for spectroscopic OCT. Harmonic detection is easily applied because it uses a simple sine- wave modulation of the interferometer, with detection at harmonics of the applied wave. Phase I of this project focuses on demonstrating spectroscopic OCT using our harmonic detection technology. In particular, a near infrared absorption feature of lipid, which is an important component of vulnerable atherosclerotic plaques, will be used to demonstrate contrast enhancement resulting from spectroscopic OCT. In Phase II, we will proceed with design and construction of a fiber-optic, cathete r probe instrument for intra-luminal imaging of arteries, with the goal of conducting Phase III clinical studies.

Principal Investigator:

Kristen A. Peterson
5059841322
PETERSON@SWSCIENCES.COM

Business Contact:


astanton@swsciences.com
Small Business Information at Submission:

SOUTHWEST SCIENCES, INC.
SOUTHWEST SCIENCES, INC. 1570 PACHECO ST, STE E-11 SANTA FE, NM 87505

EIN/Tax ID: 850340320
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No